Professor Mark Wilcox | Professor Of Medical Microbiology And Deputy-Chair, Aprhai
University of Leeds | United Kingdom

Prof. Mark Wilcox is a consultant microbiologist and the Head of Research and Development in Microbiology at the Leeds Teaching Hospitals (LTHT), where he is also the Infection Lead of Leeds NIHR Diagnostic Technologies Medical Technology and In Vitro Diagnostic Co-operative; Professor of Medical Microbiology at the University of Leeds; and Lead on Clostridium difficile for Public Health England (PHE).

He serves in numerous advisory roles including as a medical advisor to National Infection Prevention & Control Lead (NHS Improvement), England, the Medical Research Council’s Infection and Immunity Panel, and he is Chair of PHE’s Rapid Review Panel (reviews the utility of infection prevention & control products for the NHS) and Deputy Chair of the Department of Health’s Antimicrobial Prescribing and Resistance and Healthcare Associated Infection committee (APRHAI). He was formerly the Director of Infection Prevention (4 years), Infection Control Doctor (8 years), and Clinical Director of Pathology (6 years) at LTHT and Head of Microbiology (15 years). Prof Wilcox leads a Healthcare Associated Infection Research Group at the University of Leeds (http://medhealth.leeds.ac.uk/hcai), comprising ~30 doctors, scientists and nurses.

Projects include multiple aspects of Clostridium difficile infection, diagnostics, antibiotic resistance and the gut microbiome, infection prevention and control interventions, and the clinical development of new antimicrobial agents.